Table 1.
Baseline data and post-Ramadan outcomes for the 2 studied groups
| TTW group (n = 57) |
SDT group (n = 91) |
Test of sig. | p | |
|---|---|---|---|---|
| Sex | ||||
| Female | 56 (98.2%) | 84 (92.3%) | χ2 = 2.417 |
FEp= 0.153 |
| Male | 1 (1.8%) | 7 (7.7%) | ||
| Age (years) | ||||
| Mean ± SD. | 37.32 ± 11.01 | 46.97 ± 13.85 | t = 4.691* | < 0.001* |
| Median (Min. – Max.) | 37 (18–60) | 45 (17–78) | ||
| Diagnosis | ||||
| HT | 44 (77.2%) | 62 (68.1%) |
χ2= 6.901 |
FEp= 0.084 |
| Tx | 6 (10.5%) | 23 (25.3%) | ||
| RAI | 5 (8.8%) | 5 (5.5%) | ||
| PPT | 1 (1.8%) | 1 (1.1%) | ||
| Unclassified | 1 (1.8%) | 0 (0%) | ||
| Regimen number | ||||
| 1 | 37 (64.9%) | 32 (35.2%) |
χ2= 16.689* |
MCp= 0.001* |
| 2 | 17 (29.8%) | 41 (45.1%) | ||
| 3 | 3 (5.3%) | 7 (7.7%) | ||
| 4 | 0 (0%) | 11(12.1) | ||
| Adherence | ||||
| Adherent | 55 (96.5%) | 81 (89%) | χ2 = 2.632 |
FEp= 0.130 |
| Non-adherent | 2 (3.5%) | 10 (11%) | ||
| Pre-Ramadan TSH | ||||
| Mean ± SD. | 1.80 ± 0.88 | 1.39 ± 0.72 | U = 1850.5* | 0.003* |
| Median (Min. – Max.) | 1.81 (0.30–3.90) | 1.17 (0.30–3.68) | ||
| Post-Ramadan TSH | ||||
| Mean ± SD. | 2.30 ± 1.25 | 1.69 ± 1.70 | U = 1653.5* | < 0.001* |
| Median (Min. – Max.) | 2.08 (0.08–7.50) | 1.52 (0.08–15.1) | ||
| Post-Ramadan Thyroid status | ||||
| Euthyroid | 52 (91.2%) | 86 (94.5%) | χ2 = 0.598 |
FEp= 0.509 |
| Dysthyroid | 5 (8.8%) | 5 (5.5%) |
SD: Standard deviation U: Mann Whitney test t: Student t test
χ2: Chi square test FE: Fisher Exact
p: p value for comparing between the studied groups
*: significant at P value of < 0.05
TTW Twice or thrice weekly, SDT Standard daily therapy
HT Hashimoto thyroiditis, Tx thyroidectomy, RAI radioiodine ablation, PPT post-partum thyroiditis